CSL Welcomes US Court Ruling

We are encouraged by the United States Court of Appeals for the District of Columbia Circuit’s ruling that plasma companies have the legal right to challenge the Customs and Border Protection (CBP) ban on plasma donation by Mexican nationals entering the country on a B1/B2 visa. We are also pleased that the Court of Appeals’ decision acknowledges the importance of Mexican plasma donors in providing this critical resource necessary to manufacture life-saving, plasma-derived therapies.

We await further instruction from the United States District Court and will continue to challenge the plasma ban and secure a more stable plasma supply for the hundreds of thousands of patients dependent on plasma-derived therapies.

/Public Release. This material from the originating organization/author(s) may be of a point-in-time nature, edited for clarity, style and length. The views and opinions expressed are those of the author(s).View in full here.